Article info
Original research
RECIST 1.1 versus clinico-radiological response assessment for locally advanced cervical cancer: implications on interpreting survival outcomes of future trials
- Correspondence to Dr Supriya Chopra, Department of Radiation Oncology, Advanced Centre for Treatment Research and Education in Cancer, Tata Memorial Centre, Homi Bhabha National Institute, Navi Mumbai, Maharashtra, India; schopra{at}actrec.gov.in; Dr Remi A Nout, Department of Radiation Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands; r.nout{at}erasmusmc.nl
Citation
RECIST 1.1 versus clinico-radiological response assessment for locally advanced cervical cancer: implications on interpreting survival outcomes of future trials
Publication history
- Received February 12, 2024
- Accepted April 11, 2024
- First published April 22, 2024.
Online issue publication
June 03, 2024
Article Versions
- Previous version (22 April 2024).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© IGCS and ESGO 2024. No commercial re-use. See rights and permissions. Published by BMJ.